As of 4:00pm ET
| +0.40 / +3.40%|
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 28.00 and a low estimate of 15.00. The median estimate represents a +48.03% increase from the last price of 12.16.
The current consensus among 9 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.